ARCHIVES

Transplant Is Viable Option For HIV+ Patients, Study Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 2 | February 25, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

May 9, 2003

Cancer Centers Branch To Be ‘More Proactive,’ Kimes Tells NCAB

January 12, 1990

Proof of principle needed before launching “big science” program, advisors say.

March 11, 2005

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

February 22, 2013

DCT Advisors OK 4 Contract Concepts In Therapeutics

June 28, 1991

DCT Will Consider Planning, Center Core Supplemental, Program Project Grants In $5 Million Surgical Oncology Development Effort

October 10, 1980